describe that 20% of ECs (POLE-mutant, MSI and MSS) show PD-L1+ tumor cells, whereas within our high-risk cohort only 1 out of 116 tumors showed any expression of PD-L1 on the tumor cells (using the same PD-L1 antibody). Here, CD274 is linked to neoplasm.